For the month ended 28 February 2026, ALI HEALTH (00241 HK) reported that its authorized share capital remained at HKD 200.00 million, with a par value of HKD 0.01 per share. The total number of issued ordinary shares (excluding treasury shares) rose by 750 to 16,175,300,965, reflecting the exercise of share options, resulting in HKD 3,300 in funds raised.
No changes took place in treasury shares, and all relevant public float requirements were met. Details of existing share award schemes remained unchanged during the reporting period, with no additional new shares issued under other agreements or arrangements.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments